Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1976 1
1979 1
1980 1
1982 1
1989 3
1990 1
1991 1
1992 1
1993 1
1994 1
1996 1
1997 1
1998 3
1999 2
2000 3
2001 2
2002 3
2003 5
2004 3
2005 5
2006 4
2007 12
2008 15
2009 14
2010 16
2011 15
2012 24
2013 20
2014 34
2015 40
2016 31
2017 20
2018 18
2019 31
2020 43
2021 55
2022 62
2023 56
2024 52
2025 53
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

587 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH. Svoboda J, et al. Among authors: chong ea. N Engl J Med. 2025 May 8;392(18):1824-1835. doi: 10.1056/NEJMoa2408771. N Engl J Med. 2025. PMID: 40334157 Clinical Trial.
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak Ö, Brogdon JL, Pruteanu-Malinici I, Bhoj V, Landsburg D, Wasik M, Levine BL, Lacey SF, Melenhorst JJ, Porter DL, June CH. Schuster SJ, et al. Among authors: chong ea. N Engl J Med. 2017 Dec 28;377(26):2545-2554. doi: 10.1056/NEJMoa1708566. Epub 2017 Dec 10. N Engl J Med. 2017. PMID: 29226764 Free PMC article. Clinical Trial.
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P, Clurman A, Dwomoh E, Armijo G, Gomes ALC, Littmann ER, Schluter J, Fontana E, Taur Y, Park JH, Palomba ML, Halton E, Ruiz J, Jain T, Pennisi M, Afuye AO, Perales MA, Freyer CW, Garfall A, Gier S, Nasta S, Landsburg D, Gerson J, Svoboda J, Cross J, Chong EA, Giralt S, Gill SI, Riviere I, Porter DL, Schuster SJ, Sadelain M, Frey N, Brentjens RJ, June CH, Pamer EG, Peled JU, Facciabene A, van den Brink MRM, Ruella M. Smith M, et al. Among authors: chong ea. Nat Med. 2022 Apr;28(4):713-723. doi: 10.1038/s41591-022-01702-9. Epub 2022 Mar 14. Nat Med. 2022. PMID: 35288695 Free PMC article.
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. Doberer K, et al. Among authors: chong e. J Am Soc Nephrol. 2021 Mar;32(3):708-722. doi: 10.1681/ASN.2020071106. Epub 2020 Dec 18. J Am Soc Nephrol. 2021. PMID: 33443079 Free PMC article. Clinical Trial.
Immunotherapy with cells.
Chong EA, Porter DL. Chong EA, et al. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):590-597. doi: 10.1182/hematology.2020000174. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275723 Free PMC article. Review.
Cardiovascular Emergencies.
Chang YJ, Chang SL, Chong E, Suenari K, Michalopoulos A. Chang YJ, et al. Among authors: chong e. Biomed Res Int. 2017;2017:7210261. doi: 10.1155/2017/7210261. Epub 2017 Jul 2. Biomed Res Int. 2017. PMID: 28752094 Free PMC article. No abstract available.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Ghilardi G, Fraietta JA, Gerson JN, Van Deerlin VM, Morrissette JJD, Caponetti GC, Paruzzo L, Harris JC, Chong EA, Susanibar Adaniya SP, Svoboda J, Nasta SD, Ugwuanyi OH, Landsburg DJ, Fardella E, Waxman AJ, Chong ER, Patel V, Pajarillo R, Kulikovskaya I, Lieberman DB, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Hexner EO, Barta SK, Porter DL, Garfall AL, Schuster SJ, June CH, Ruella M. Ghilardi G, et al. Among authors: chong er, chong ea. Nat Med. 2024 Apr;30(4):984-989. doi: 10.1038/s41591-024-02826-w. Epub 2024 Jan 24. Nat Med. 2024. PMID: 38266761
A deep-learning retinal aging biomarker for cognitive decline and incident dementia.
Sim MA, Tham YC, Nusinovici S, Quek TC, Yu M, Xue CC, Chee ML, Peng QS, Tan ESJ, Chan SP, Cai Y, Chong EJY, Tan BY, Venketasubramanian N, Hilal S, Lai MKP, Choi H, Richards AM, Cheng CY, Chen CLH. Sim MA, et al. Among authors: chong ejy. Alzheimers Dement. 2025 Mar;21(3):e14601. doi: 10.1002/alz.14601. Alzheimers Dement. 2025. PMID: 40042460 Free PMC article.
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study.
Yegya-Raman N, Plastaras JP, Wright CM, Chelius M, Zhang S, Baron JA, Hubbeling H, Sim AJ, Robinson TJ, Jain MD, Imber B, Fregonese B, Yahalom J, Ladbury C, Dandapani S, Pinnix CC, Gunther JR, Fang PQ, Wu SY, Dabaja BS, Yang JC, Chew J, Braunstein S, Sinha S, Delinger NM, Sun S, Terezakis SA, Sakthivel G, Constine LS, Chowdhry AK, Reagan PM, Burke S, Tseng YD, LaRiviere MJ, Maity A, Schuster SJ, Chong EA, Figura NB. Yegya-Raman N, et al. Among authors: chong ea. Blood Adv. 2025 Jul 8;9(13):3293-3303. doi: 10.1182/bloodadvances.2025015855. Blood Adv. 2025. PMID: 40203192 Free PMC article.
587 results